查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
智能吸入器市场规模,份额和趋势分析报告：按类型（干粉/定量吸入器）,适应症（哮喘,慢性阻塞性肺病）,分销渠道,最终用途,地区,细分市场预测2022-2030
市场调查报告书
商品编码
1170894

智能吸入器市场规模,份额和趋势分析报告：按类型（干粉/定量吸入器）,适应症（哮喘,慢性阻塞性肺病）,分销渠道,最终用途,地区,细分市场预测2022-2030

Smart Inhalers Market Size, Share & Trends Analysis Report By Type (Dry Powdered Inhalers, Metered Dose Inhalers), By Indication (Asthma, COPD), By Distribution Channel, By End-use, By Region, And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

智能吸入器市场增长和趋势

根据 Grand View Research, Inc. 的一份新报告，到 2030 年，全球智能吸入器市场规模预计将达到 533 亿美元，2022 年至 2030 年的复合年增长率为 19.3%。哮喘、慢性阻塞性肺病 (COPD)、囊性纤维化和肺部疾病等慢性呼吸系统疾病 (CRD) 患病率上升有助于市场增长。据欧洲呼吸学会大会称，COPD 预计到 2022 年将影响全球超过 4.8 亿人。

由于用于呼吸和肺部护理的尖端数字设备和解决方案日益普及，COVID-19 增加了对智能吸入器的需求。此外，在大流行后时代，智能吸入器的采用率正在上升，因为医疗保健提供者希望连接的医疗设备能够帮助患者在任何情况下都获得更好、更好的护理。

此外，越来越多的企业将数字技术融入到他们的产品中，以提高用药效率和管理哮喘和慢性阻塞性肺病。同样在 2022 年 4 月，市场领导者 Aptar Pharma 宣布推出 HeroTracker Sense，这是一种新型数字慢性呼吸电子健康解决方案，可将传统计量吸入器转变为智能吸入器。此外，对 Aderium 智能吸入器的研究还表明，智能吸入器用户获得了多项有益的医疗成果，包括住院时间减少、服药依从性提高以及就诊需求减少。

智能吸入器市场报告要点

按类型划分，计量吸入器 (MDI) 部分将在 2021 年占据最大份额，超过 60.0%。MDI 是用于治疗 CRD 的最优选吸入器。干粉吸入器 (DPI) 部分预计在预测期内以 18.6% 的最快速度增长，这是由于易于使用的给药机制带来的便利。

据指征，慢阻肺的患病率很高，全球有2亿人受到影响，到2021年，慢阻肺细分市场将占据最大份额，超过50.0%。由于哮喘住院人数增加，尤其是幼儿，预计在预测期内，哮喘部分将以 18.3% 的最快速度增长。

从分销渠道来看，2021年医院药房板块占比最大，超过40.0%。老年人经常因 CRD 住院治疗，我们正在考虑到医院药房购买药物。由于现有药店的快速扩张和现代化以提高市场渗透率，预计零售药店部门在预测期内将以 19.2% 的速度增长

按最终用户划分，医院部分将在 2021 年占据最大份额，超过 50.0%，因为医院是製药公司与患者之间的重要分销渠道。家庭医疗环境领域预计在预测期内将以最快的速度增长 20.2%，这是受老年患者偏好上升、医疗成本上升以及家庭护理提供的便利性推动。

2021 年，由于 CRD 在该地区的流行率上升，北美以超过 45.0% 的份额主导了市场。美国有超过 2500 万人患有哮喘病。由于中国和印度等发展中国家慢性阻塞性肺病和哮喘发病率上升，预计亚太地区在预测期内将以最快的速度增长 21.2%

目录

第一章研究范围与目的

  • 市场细分和范围
  • 区域范围
  • 目的

第二章研究方法论

  • 调查方法
  • 信息采购
    • 购买的数据库
    • GVR内部数据库
    • 次要信息
    • 初步调查
  • 信息或数据分析
    • 数据分析模型
  • 市场製定和验证
  • 型号详情
    • 商品流向分析（模型一）
    • 量价分析（模型二）
  • 二级信息列表

第三章执行摘要

  • 市场展望
  • 分部展望
    • 类型
    • 展示
    • 分销渠道
    • 最终用途
    • 地区
  • 竞争考虑
  • 2021 年智能吸入器市场展望

第 4 章市场变量、趋势和范围

  • 市场系列展望
    • 母公司市场展望
    • 辅助市场展望
  • 智能吸入器市场动态
    • 市场驱动力分析
    • 市场约束因素分析
  • 智能吸入器市场：商业环境分析工具
    • 波特五力分析
      • 新进入者的威胁
      • 供应商的议价能力
      • 买方议价能力
      • 竞争对手之间的竞争
      • 替代品的威胁
    • PESTEL 分析
      • 政治与法律
      • 经济与社会
      • 技术的
      • 环境
  • 绘製渗透率和增长前景
  • 技术趋势分析
  • 监管框架
  • COVID-19 对智能吸入器市场的影响

第五章智能吸入器市场：类型分析

  • 2021 年和 2030 年智能吸入器类型市场份额分析
  • 智能吸入器类型市场：细分仪表板
  • 类型细分市场规模和预测，趋势分析，2017-2030
    • 干粉吸入器
    • 定量吸入器

6. 智能吸入器市场：适应症分析

  • 2021 年和 2030 年智能吸入器适应症市场份额分析
  • 智能吸入器适应市场：细分仪表板
  • 2017-2030年适应症细分市场规模及预测、趋势分析
    • 哮喘
    • Copd
    • 其他

第七章智能吸入器市场：分销渠道分析

  • 2021 年和 2030 年智能吸入器分销渠道市场份额分析
  • 智能吸入器分销渠道市场：细分仪表板
  • 分销渠道市场规模和预测，趋势分析，2017-2030
    • 医院药房
    • 零售药店
    • 网上药店

8. 智能吸入器市场：最终用途分析

  • 智能吸入器最终用途市场份额分析，2021 年和 2030 年
  • 智能吸入器最终用途市场：细分仪表板
  • 2017-2030 年最终用途细分市场规模及预测及趋势分析
    • 医院
    • 家庭护理设置
    • 其他

第 9 章智能吸入器市场：区域分析

  • 智能吸入器区域市场份额分析，2021 年和 2030 年
  • 区域市场快照
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 意大利
    • 西班牙
    • 俄罗斯
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 韩国
    • 新加坡
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲 (MEA)
    • 南非
    • 沙特阿拉伯
    • 阿拉伯联合酋长国

第 10 章 竞争分析

  • 主要市场进入者的最新发展和影响分析
  • 公司简介
    • H&T PRESSPART MANUFACTURING LTD.
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • PERSONAL AIR QUALITY SYSTEMS PRIVATE LIMITED
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • COHERO HEALTH INC.
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • COGNITA LABS
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • ADHERIUM LIMITED
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • AMIKO DIGITAL HEALTH LIMITED
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • TEVA PHARMACEUTICALS INDUSTRIES LTD.
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • PROPELLER HEALTH
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • NOVARTIS AG
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • PNEUMA RESPIRATORY, INC.
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • 3M HEALTH CARE LIMITED
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • FINDAIR SP Z O O
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • AIREHEALTH, INC.
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
Product Code: GVR-4-68039-993-1

Smart Inhalers Market Growth & Trends:

The global smart inhalers market size is expected to reach USD 53.3 billion by 2030, based on a new report by Grand View Research, Inc., expanding at a CAGR of 19.3% from 2022 to 2030. The rising prevalence of chronic respiratory diseases (CRDs) such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and lung disorders is contributing to the growth of the market. According to the European Respiratory Society Congress, COPD is expected to affect over 480 million people in 2022 across the globe.

COVID-19 has increased the demand for smart inhalers due to the rising penetration of cutting-edge digital devices and solutions for respiratory and pulmonary care. Furthermore, in the post-pandemic era, it is expected that the adoption of smart inhalers will increase as healthcare providers are focusing on connected medical devices to ensure that patients receive better and more enhanced care, regardless of the circumstance.

Furthermore, a growing number of businesses are incorporating digital technologies into their products to improve the efficiency of medication and the management of asthma and COPD. In addition, in April 2022, Aptar Pharma, a key market player, introduced HeroTracker Sense, a novel digital chronic respiratory e-health solution that converts a traditional metered dose inhaler into a smart inhaler. Furthermore, a study of the Adherium Smart inhaler also revealed that smart inhaler users experienced several beneficial medical outcomes, including fewer hospitalizations, improved medication adherence, and a decreased need for doctor visits.

Smart Inhalers Market Report Highlights:

  • Based on type, the metered dose inhalers (MDIs) segment held the largest share of over 60.0% in 2021. MDIs are the most preferred inhalers used to treat CRDs. The dry powdered inhalers (DPIs) segment is expected to register the fastest growth rate of 18.6% over the forecast period owing to the convenience of its mechanism, which makes it easier to use for medicine delivery
  • Based on indication, the COPD segment held the largest share of over 50.0% in 2021 due to the high prevalence of COPD as it affects 200 million people globally. The asthma segment is anticipated to grow at the fastest rate of 18.3% over the forecast period owing to the rising number of hospitalizations for asthma, particularly in young children
  • Based on distribution channel, the hospital pharmacies segment held the largest share of over 40.0% in 2021. The elderly population frequently receives hospital care for CRDs, and they consider purchasing medication from hospital pharmacies. The retail pharmacies segment is anticipated to grow at a rate of 19.2% over the forecast period due to the quick expansion and modernization of the existing pharmacies to increase market penetration
  • Based on end-use, the hospitals segment accounted for the largest share of over 50.0% in 2021 as hospitals are a crucial distribution channel between pharmaceutical companies and patients. The home care settings segment is anticipated to grow at the fastest rate of 20.2% over the forecast period due to the growing preference among older patients, rising costs of healthcare, and the convenience offered by the treatments at home
  • In 2021, North America dominated the market with a share of over 45.0% owing to the rising prevalence of CRDs in the region. In the U.S., more than 25 million people suffer from asthma. Asia Pacific is expected to expand at the fastest rate of 21.2% during the forecast period owing to rising incidence rates of COPD and asthma in developing nations such as China and India

Table of Contents

Chapter 1 Report Scope and Objectives

  • 1.1 Market Segmentation & Scope
  • 1.2 Regional Scope
    • 1.2.1 Estimates And Forecast Timeline
  • 1.3 Objectives
    • 1.3.1 Objective - 1
    • 1.3.2 Objective - 2
    • 1.3.3 Objective - 3

Chapter 2 Methodology

  • 2.1 Research Methodology
  • 2.2 Information Procurement
    • 2.2.1 Purchased Database
    • 2.2.2 Gvr's Internal Database
    • 2.2.3 Secondary Sources
    • 2.2.4 Primary Research
  • 2.3 Information or Data Analysis
    • 2.3.1 Data Analysis Models
  • 2.4 Market Formulation & Validation
  • 2.5 Model Details
    • 2.5.1 Commodity Flow Analysis (Model 1)
    • 2.5.2 Volume Price Analysis (Model 2)
  • 2.6 List of Secondary Sources

Chapter 3 Executive Summary

  • 3.1 Market Outlook
  • 3.2 Segment Outlook
    • 3.2.1 type
    • 3.2.2 Indication
    • 3.2.3 distribution Channel
    • 3.2.4 end-Use
    • 3.2.5 Region
  • 3.3 Competitive Insights
  • 3.4 Smart Inhalers Market Outlook, 2021

Chapter 4 Market Variables, Trends & Scope

  • 4.1 Market Lineage Outlook
    • 4.1.1 Parent Market Outlook
    • 4.1.2 Ancillary Market Outlook
  • 4.2 Smart Inhalers Market Dynamics
    • 4.2.1 Market Driver Analysis
    • 4.2.2 Market Restraint Analysis
  • 4.3 Smart Inhalers Market: Business Environment Analysis Tools
    • 4.3.1 Porter's Five Forces Analysis
      • 4.3.1.1 Threat Of New Entrants
      • 4.3.1.2 Bargaining Power Of Suppliers
      • 4.3.1.3 Bargaining Power Of Buyers
      • 4.3.1.4 Competitive Rivalry
      • 4.3.1.5 Threat Of Substitutes
    • 4.3.2 Pestel Analysis
      • 4.3.2.1 Political & Legal
      • 4.3.2.2 Economic & social
      • 4.3.2.3 Technological
      • 4.3.2.4 Environmental
  • 4.4 Penetration & Growth Prospect Mapping
  • 4.5 Technology Trend Analysis
  • 4.6 Regulatory Framework
  • 4.7 Impact of COVID-19 on Smart Inhalers Market

Chapter 5 Smart Inhalers Market: Type Analysis

  • 5.1 Smart Inhalers Type Market Share Analysis, 2021 & 2030
  • 5.2 Smart Inhalers Type Market: Segment Dashboard
  • 5.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the Type Segment
    • 5.3.1 Dry Powdered Inhalers
      • 5.3.1.1 Dry Powdered Inhalers (Dpis) Market, 2017 - 2030 (USD Million)
    • 5.3.2 Metered Dose Inhalers
      • 5.3.2.1 Metered dose inhalers (MDIs) market, 2017 - 2030 (USD Million)

Chapter 6 Smart Inhalers Market: Indication Analysis

  • 6.1 Smart Inhalers Indication Market Share Analysis, 2021 & 2030
  • 6.2 Smart Inhalers Indication Market: Segment Dashboard
  • 6.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the Indication Segment
    • 6.3.1 Asthma3
      • 6.3.1.1 Asthma Market, 2017 - 20302017 - 20302017 - 2030 (USD Million)
    • 6.3.2 Copd
      • 6.3.2.1 Copd Market, 2017 - 2030 (USD Million)
    • 6.3.3 Others
      • 6.3.3.1 Others market, 2017 - 2030 (USD Million)

Chapter 7 Smart Inhalers Market: Distribution Channel Analysis

  • 7.1 Smart Inhalers Distribution Channel Market Share Analysis, 2021 & 2030
  • 7.2 Smart Inhalers Distribution Channel Market: Segment Dashboard
  • 7.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the Distribution Channel
    • 7.3.1 Hospitals Pharmacies
      • 7.3.1.1 Hospitals Pharmacies Market, 2017 - 2030 (USD Million)
    • 7.3.2 Retail Pharmacies
      • 7.3.2.1 Retail Pharmacies Market, 2017 - 2030 (USD Million)
    • 7.3.3 Online Pharmacies
      • 7.3.3.1 Online pharmacies market, 2017 - 2030 (USD Million)

Chapter 8 Smart Inhalers Market: End-Use Analysis

  • 8.1 Smart Inhalers end-use Market Share Analysis, 2021 & 2030
  • 8.2 Smart Inhalers End-Use Market: Segment Dashboard
  • 8.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the End-Use Segment
    • 8.3.1 Hospitals
      • 8.3.1.1 Hospitals Market, 2017 - 2030 (USD Million)
    • 8.3.2 Homcare Settings
      • 8.3.2.1 Homecare Settings Market, 2017 - 2030 (USD Million)
    • 8.3.3 Others
      • 8.3.3.1 Others market, 2017 - 2030 (USD Million)

Chapter 9 Smart Inhalers Market: Regional Analysis

  • 9.1 Smart Inhalers Regional Market Share Analysis, 2021 & 2030
  • 9.2 Regional Market Snapshot
  • 9.3 North America
    • 9.3.1 North America Smart Inhalers Market, 2017 - 2030 (USD Million)
    • 9.3.2 U.S.
      • 9.3.2.1 U.S. Smart Inhalers Market, 2017 - 2030 (USD Million)
    • 9.3.3 Canada
      • 9.3.3.1 Canada Smart Inhalers Market, 2017 - 2030 (USD Million)
  • 9.4 Europe
    • 9.4.1 Europe Smart Inhalers Market, 2017 - 2030 (USD Million)
    • 9.4.2 U.K.
      • 9.4.2.1 U.K. Smart Inhalers Market, 2017 - 2030 (USD Million)
    • 9.4.3 Germany
      • 9.4.3.1 Germany Smart Inhalers Market, 2017 - 2030 (USD Million)
    • 9.4.4 France
      • 9.4.4.1 France smart inhalers market, 2017 - 2030 (USD Million)
    • 9.4.5 Italy
      • 9.4.5.1 Italy Smart Inhalers Market, 2017 - 2030 (USD Million)
    • 9.4.6 Spain
      • 9.4.6.1 Spain Smart Inhalers Market, 2017 - 2030 (USD Million)
    • 9.4.7 Russia
      • 9.4.7.1 Russia smart inhalers market, 2017 - 2030 (USD Million)
  • 9.5 Asia Pacific
    • 9.5.1 Asia Pacific Smart Inhalers Market, 2017 - 2030 (USD Million)
    • 9.5.2 Japan
      • 9.5.2.1 Japan Smart Inhalers Market, 2017 - 2030 (USD Million)
    • 9.5.3 China
      • 9.5.3.1 China Smart Inhalers Market, 2017 - 2030 (USD Million)
    • 9.5.4 India
      • 9.5.4.1 India Smart Inhalers Market, 2017 - 2030 (USD Million)
    • 9.5.5 Australia
      • 9.5.5.1 Australia Smart Inhalers Market, 2017 - 2030 (USD Million)
    • 9.5.6 South Korea
      • 9.5.6.1 South Korea Smart Inhalers Market, 2017 - 2030 (USD Million)
    • 9.5.7 Singapore
      • 9.5.7.1 Singapore Smart inhalers market, 2017 - 2030 (USD Million)
  • 9.6 Latin America
    • 9.6.1 Latin America Smart Inhalers Market, 2017 - 2030 (USD Million)
    • 9.6.2 Brazil
      • 9.6.2.1 Brazil Smart Inhalers Market, 2017 - 2030 (USD Million)
    • 9.6.3 Mexico
      • 9.6.3.1 Mexico Smart Inhalers Market, 2017 - 2030 (USD Million)
    • 9.6.4 Argentina
      • 9.6.4.1 Argentina Smart Inhalers market, 2017 - 2030 (USD Million)
  • 9.7 Middle East and Africa (MEA)
    • 9.7.1 MEA Smart Inhalers Market, 2017 - 2030 (USD Million)
    • 9.7.2 South Africa
      • 9.7.2.1 South Africa Smart Inhalers Market, 2017 - 2030 (USD Million)
    • 9.7.3 Saudi Arbia
      • 9.7.3.1 Saudi Arbia smart inhalers market, 2017 - 2030 (USD Million)
    • 9.7.4 UAE
      • 9.7.4.1 UAE smart inhalers market, 2017 - 2030 (USD Million)

Chapter 10 Competitive Analysis

  • 10.1 Recent Developments & Impact Analysis, By Key Market Participants
  • 10.2 Company Profiles
    • 10.2.1 H&T PRESSPART MANUFACTURING LTD.
      • 10.2.1.1 Company overview
      • 10.2.1.2 Financial performance
      • 10.2.1.3 Product benchmarking
      • 10.2.1.4 Strategic initiatives
    • 10.2.2 PERSONAL AIR QUALITY SYSTEMS PRIVATE LIMITED
      • 10.2.2.1 Company overview
      • 10.2.2.2 Financial performance
      • 10.2.2.3 Product benchmarking
      • 10.2.2.4 Strategic initiatives
    • 10.2.3 COHERO HEALTH INC.
      • 10.2.3.1 Company overview
      • 10.2.3.2 Financial performance
      • 10.2.3.3 Product benchmarking
      • 10.2.3.4 Strategic initiatives
    • 10.2.4 COGNITA LABS
      • 10.2.2.1 Company overview
      • 10.2.2.2 Financial performance
      • 10.2.2.3 Product benchmarking
      • 10.2.2.4 Strategic initiatives
    • 10.2.4 ADHERIUM LIMITED
      • 10.2.4.1 Company overview
      • 10.2.4.2 Financial performance
      • 10.2.4.3 Product benchmarking
      • 10.2.4.4 Strategic initiatives
    • 10.2.5 AMIKO DIGITAL HEALTH LIMITED
      • 10.2.5.1 Company overview
      • 10.2.5.2 Financial performance
      • 10.2.5.3 Product benchmarking
      • 10.2.5.4 Strategic initiatives
    • 10.2.6 TEVA PHARMACEUTICALS INDUSTRIES LTD.
      • 10.2.6.1 Company overview
      • 10.2.6.2 Financial performance
      • 10.2.6.3 Product benchmarking
      • 10.2.6.4 Strategic initiatives
    • 10.2.7 PROPELLER HEALTH
      • 10.2.7.1 Company overview
      • 10.2.7.2 Financial performance
      • 10.2.7.3 Product benchmarking
      • 10.2.7.4 Strategic initiatives
    • 10.2.8 NOVARTIS AG
      • 10.2.8.1 Company overview
      • 10.2.8.2 Financial performance
      • 10.2.8.3 Product benchmarking
      • 10.2.8.4 Strategic initiatives
    • 10.2.9 PNEUMA RESPIRATORY, INC.
      • 10.2.9.1 Company overview
      • 10.2.9.2 Financial performance
      • 10.2.9.3 Product benchmarking
      • 10.2.9.4 Strategic initiatives
    • 10.2.10 3M HEALTH CARE LIMITED
      • 10.2.10.1 Company overview
      • 10.2.10.2 Financial performance
      • 10.2.10.3 Product benchmarking
      • 10.2.10.4 Strategic initiatives
    • 10.2.11 FINDAIR SP. Z O.O.
      • 10.2.11.1 Company overview
      • 10.2.11.2 Financial performance
      • 10.2.11.3 Product benchmarking
      • 10.2.11.4 Strategic initiatives
    • 10.2.12 AIREHEALTH, INC.
      • 10.2.12.1 Company overview
      • 10.2.12.2 Financial performance
      • 10.2.12.3 Product benchmarking
      • 10.2.12.4 Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 North America smart inhalers market estimates and forecasts, by country, 2017 - 2030 (USD Million)
  • Table 3 North America smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 4 North America smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 5 North America smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 6 North America smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 7 U.S. smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 8 U.S. smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 9 U.S. smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 10 U.S. smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 11 Canada smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 12 Canada smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 13 Canada smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 14 Canada smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 15 Europe smart inhalers market estimates and forecasts, by country, 2017 - 2030 (USD Million)
  • Table 16 Europe smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 17 Europe smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 18 Europe smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 19 Europe smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 20 U.K. smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 21 U.K. smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 22 U.K. smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 23 U.K. smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 24 Germany smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 25 Germany smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 26 Germany smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 27 Germany smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 28 France smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 29 France smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 30 France smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 31 France smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 32 Italy smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 33 Italy Smart Inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 34 Italy smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 35 Italy smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 36 Spain smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 37 Spain smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 38 Spain smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 39 Spain smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 40 Russia smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 41Russia smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 42 Russia smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 43 Russia smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 44 Asia Pacific smart inhalers market estimates and forecasts, by country, 2017 - 2030 (USD Million)
  • Table 45 Asia Pacific smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 46 Asia Pacific smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 47 Asia Pacific smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 48 Asia Pacific smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 49 Japan smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 50 Japan smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 51 Japan smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 52 Japan smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 53 China smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 54 China smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 55 China smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 56 China smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 57 India smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 58 India smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 59 India smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 60 India smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 61 Australia smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 62 Australia smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 63 Australia smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 64 Australia smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)'
  • Table 61 South Korea smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 62 South Korea smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 63 South Korea smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 64 South Korea smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 61 Singapore smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 62 Singapore smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 63 Singapore smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 64 Singapore smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 65 Latin America smart inhalers market estimates and forecasts, by country, 2017 - 2030 (USD Million)
  • Table 66 Latin America smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 67 Latin America smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 68 Latin America smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 69 Latin America smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 70 Brazil smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 71 Brazil smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 72 Brazil smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 73 Brazil smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 74 Mexico smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 75 Mexico smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 76 Mexico smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 77 Mexico smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 74 Argentina smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 75 Argentina smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 76 Argentina smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 77 Argentina smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 78 MEA smart inhalers market estimates and forecasts, by country, 2017 - 2030 (USD Million)
  • Table 71 MEA smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 72 MEA smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 73 MEA smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 74 MEA smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 75 South Africa smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 76 South Africa smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 77 South Africa smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 78 South Africa smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 75 Saudi Arabia smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 76 Saudi Arabia smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 77 Saudi Arabia smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 78 Saudi Arabia smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
  • Table 75 UAE smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
  • Table 76 UAE smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
  • Table 77 UAE smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
  • Table 78 UAE smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)

List of Figures

  • Fig. 1 Smart inhalers market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Smart Inhalers market outlook, 2021 (USD Million)
  • Fig. 10 Market trends & outlook
  • Fig. 11 Market driver relevance analysis (Current & future impact)
  • Fig. 12 Market restraint relevance analysis (Current & future impact)
  • Fig. 13 Penetration & growth prospect mapping
  • Fig. 14 Smart inhalers type market share analysis, 2022 & 2030 (USD Million)
  • Fig. 15 Smart inhalers type market: Segment dashboard
  • Fig. 16 Metered dose inhalers (MDIs) market, 2017 - 2030 (USD Million)
  • Fig. 17 Dry powdered inhalers (DPIs) market, 2017 - 2030 (USD Million)
  • Fig. 18 Smart inhalers indication market share analysis, 2021 & 2030 (USD Million)
  • Fig. 19 Smart inhalers indication market: Segment dashboard
  • Fig. 20 Asthma market, 2017 - 2030 (USD Million)
  • Fig. 21 COPD market, 2017 - 2030 (USD Million)
  • Fig. 22 Others market, 2017 - 2030 (USD Million)
  • Fig. 23 Smart inhalers distribution channel market share analysis, 2021 & 2030 (USD Million)
  • Fig. 24 Smart inhalers distribution channel market: Segment dashboard
  • Fig. 25 Hospital pharmacies market, 2017 - 2030 (USD Million)
  • Fig. 26 Retail pharmacies market, 2017 - 2030 (USD Million)
  • Fig. 27 Online pharmacies market, 2017 - 2030 (USD Million)
  • Fig. 28 Smart inhalers end-use market share analysis, 2021 & 2030 (USD Million)
  • Fig. 29 Smart inhalers end-use market: Segment dashboard
  • Fig. 30 Hospitals market segmentation market, 2017 - 2030 (USD Million)
  • Fig. 31 Homecare settings market segmentation market, 2017 - 2030 (USD Million)
  • Fig. 32 Smart inhalers regional market share analysis, 2021 & 2030 (USD Million)
  • Fig. 33 Regional market place: Key takeaways
  • Fig. 34 North America smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 35 U.S. smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 36 Canada smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 37 Europe smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 38 U.K. smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 39 Germany smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 40 France smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 41 Italy smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 42 Spain smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 42 Russia smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 43 Asia Pacific smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 44 Japan smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 45 China smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 46 India smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 46 Australia smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 46 South Korea smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 46 Singapore smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 47 Latin America smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 48 Brazil smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 49 Mexico smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 49 Argentina smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 50 MEA smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 51 South Africa smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 51 Saudi Arabia smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 51 UAE smart inhalers market, 2017 - 2030 (USD Million)
  • Fig. 52 Strategy framework